Evaluating only Future Meat Technologies’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Regulation.
Key Events Timeline
FOUNDING
Yaakov Nahmias and Rom Kshuk founded Future Meat Technologies in Jerusalem to grow meat from fibroblast cells.
FUNDING
Raised $347M Series B led by ADM Ventures; claimed $7.70/kg cultivated chicken production cost.
REGULATORY ACTION
FDA signaled slower-than-expected US approval pathway, derailing commercialization timeline.
ACQUISITION ATTEMPT
Merged with Believer Meats in distressed deal; original Israeli operations wound down through 2024.
Full Analysis
Free · no account needed
Documented cause
Future Meat raised $347M and claimed to produce cultivated chicken at $7.70/kg — a claimed cost breakthrough. CEO Rom Kshuk and founder Yaakov Nahmias built a facility in Rehovot but faced US regulatory barriers after FDA created uncertainty about approval timelines in 2023. The company merged with Believer Meats in 2023 in a distressed consolidation deal, effectively ending Future Meat as an independent entity with its original Israeli operations winding down by 2024.
Lesson
“Cost claims without regulatory approval are marketing, not milestones — investors learned this expensively.”
Failure anatomy
Collapse type
Acqui-hire
📉 MEDIUM
// engine intelligence on Future Meat Technologies
Tier 1 · instant unlock🔒 free account
Loading engine analysis…
Tier 2 · the productAnalyst · €149/mo
What you see retrospectively on Future Meat Technologies, applied predictively to your companies:
→Cross-reference this pattern against your live portfolio
→Alerts when a company you track starts matching this profile